Login to Your Account

Biogen, IDEC Planning Merger To Form Biotech Powerhouse'

By Randall Osborne

Tuesday, June 24, 2003
In a planned stock-swap "merger of equals," Biogen Inc. and IDEC Pharmaceuticals Inc. said they have entered an agreement that would create a combined entity with a market cap of $13.7 billion, the third-largest biotechnology firm based on revenue, profits and research and development spending.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription